Abbott Laboratories (ABT) EBT Margin (2009 - 2026)
Abbott Laboratories (ABT) posted EBT Margin of 12.1% for Q2 2026, down 6.76% sequentially from 12.98% in Q1 2026, and down 719.0% YoY from 1.96% in Q2 2025.
Abbott Laboratories (ABT) EBT Margin (2009 - 2026) Analysis & Trends
Abbott Laboratories has reported EBT Margin for 18 years, with the latest figure at 12.1% in Q2 2026.
- Quarterly EBT Margin fell 719.0% year-over-year to 12.1% in Q2 2026, while the trailing twelve-month figure through Jun 2026 was 16.12% (down 220.0% YoY) and the FY2025 annual result came in at 19.1%, up 238.0% from the prior year.
- EBT Margin fell to 12.1% in Q2 2026 per ABT's latest filing, from 12.98% in the prior quarter.
- Over five years, EBT Margin peaked at 24.18% in Q1 2022 and troughed at 12.1% in Q2 2026.
- A 5-year average of 17.19% and a median of 17.03% in 2025 frame the typical range for EBT Margin.
- The sharpest annual moves came in 2022 and 2023: EBT Margin jumped 771 bps in 2022, then slumped 815 bps in 2023.
- Over 5 years, EBT Margin stood at 13.08% in 2022, then surged by 34 bps to 17.53% in 2023, then increased by 6 bps to 18.5% in 2024, then grew by 11 bps to 20.58% in 2025, then sank by 41 bps to 12.1% in 2026.
- According to Business Quant data, EBT Margin over the past three periods registered 12.1%, 12.98%, and 20.58% for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.08 Bn | 194.48 Bn | 7.27 Bn | 12.10% |
| 2 | Stryker | 129.71 Bn | 126.23 Bn | 4.50 Bn | 23.74% |
| 3 | Medtronic | 120.07 Bn | 110.85 Bn | 6.41 Bn | 18.70% |
| 4 | Boston Scientific | 74.08 Bn | 73.54 Bn | 3.85 Bn | 19.48% |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.43 Bn | 1.35 Bn | 29.86% |
| 6 | Dexcom | 34.51 Bn | 32.56 Bn | 830.00 Mn | 24.27% |
| 7 | GE HealthCare Technologies | 34.03 Bn | 31.92 Bn | 2.18 Bn | 13.09% |
| 8 | Koninklijke Philips | 26.51 Bn | 23.19 Bn | 4.55 Bn | 8.91% |
| 9 | Steris | 23.20 Bn | 22.72 Bn | 684.20 Mn | 18.32% |
| 10 | Zimmer Biomet Holdings | 19.37 Bn | 18.96 Bn | 1.54 Bn | 11.72% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 12.10% |
| Mar 31, 2026 | 12.98% |
| Dec 31, 2025 | 20.58% |
| Sep 30, 2025 | 19.17% |
| Jun 30, 2025 | 19.30% |
| Mar 31, 2025 | 17.17% |
| Dec 31, 2024 | 18.50% |
| Sep 30, 2024 | 18.24% |
| Jun 30, 2024 | 15.49% |
| Mar 31, 2024 | 14.41% |
| Dec 31, 2023 | 17.53% |
| Sep 30, 2023 | 16.47% |
| Jun 30, 2023 | 16.40% |
| Mar 31, 2023 | 16.03% |
| Dec 31, 2022 | 13.08% |
| Sep 30, 2022 | 16.89% |
| Jun 30, 2022 | 20.89% |
| Mar 31, 2022 | 24.18% |
| Dec 31, 2021 | 20.29% |
| Sep 30, 2021 | 22.81% |